Has Stuart Knechtle, MD received payments from drug or device companies?

Yes. Drug and device makers reported $88,346 in general payments to Stuart Knechtle, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stuart Knechtle, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stuart Knechtle, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stuart Knechtle, MD

Transplant Surgery · Atlanta, GANPI 1013971670

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $58,052 of the $88,346 with a category attached, or 65.7%. 10 manufacturers reported payments, led by Otsuka Pharmaceutical Co., Ltd. at 24.9% of the total. Among transplant surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$88,346in general payments, 2019–2025

Across 51 payments — averaging $1732.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka Pharmaceutical Co., Ltd.$22K
Sanofi-aventis U.S. LLC$16K
CSL Behring$14K
Sanofi$12K
Mallinckrodt Hospital Products Inc.$11K
Regeneron$7K
plus $7K from 4 others

$1,747,812in research payments, 2019–2025

Across 258 payments — averaging $6774.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

CSL Behring$1M
AstraZeneca$433K
Merck$237K
E.r. Squibb & Sons, L.L.C.$40K
Regeneron$739

What the payments were for

Consulting fees$58,05266%
Speaking & faculty fees$23,24526%
Travel & lodging$5,7687%
Food & beverage$1,2811%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka Pharmaceutical Co., Ltd.	10	$22,000
Sanofi-aventis U.S. LLC	5	$16,201
CSL Behring	6	$13,794
Sanofi	10	$11,807
Mallinckrodt Hospital Products Inc.	1	$10,500
Regeneron	13	$7,229
AstraZeneca	2	$3,376
Pfizer	1	$1,750
One Lambda, Inc.	2	$1,523
Organox Ltd	1	$167

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REZUROCK$16,201
THYMOGLOBULIN$11,547
UVADEX$10,500
ATGAM$1,750
METRA$167

How this compares

$88,346 in reported general payments places this provider in the 95th percentile of 29 transplant surgery providers in Georgia.

See all transplant surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$37,893

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Atlanta

Nicole TurgeonAtlanta$130K
Allan KirkAtlanta$80K
Andrew AdamsAtlanta$60K
Evan WeitmanAtlanta$40K
Clark KensingerAtlanta$35K
Juliano RiellaAtlanta$15K
Harrison PollingerAtlanta$9K
Marty SellersAtlanta$4K
Jonathan HundleyAtlanta$4K
Steven KimAtlanta$3K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →